Overview of X-FORCE

Quick Facts

Property	Description
Active Ingredient	Sildenafil (as Sildenafil Citrate)
Form	Oral tablet (typically film-coated)
Pharmacological Class	Selective Phosphodiesterase type 5 (PDE5) Inhibitor
General Purpose	Enhancing localized blood flow
Origin	Synthetic compound

What Type of Medicine is X-FORCE?

X-FORCE is a synthetic pharmaceutical preparation whose active component is Sildenafil Citrate. It is classified as a highly selective Phosphodiesterase type 5 (PDE5) inhibitor. This categorization places the drug within a specific class of compounds designed to modulate the vascular system, an action utilized for circulatory-related management. Sildenafil, as a PDE5 inhibitor, acts on the cGMP-specific phosphodiesterase type 5 enzyme. This means the medicine works by specifically targeting a single enzyme to achieve its therapeutic effect.

As a member of the PDE5 inhibitor class, X-FORCE is a highly targeted compound. Its origin is a synthetic pyrazolo-pyrimidinone derivative, which means it is manufactured via chemical synthesis rather than being derived from natural sources. This structure ensures a consistent and predictable pharmacological profile.

The Composition and Form of X-FORCE

The core active ingredient in X-FORCE is Sildenafil, which is administered as the salt, Sildenafil Citrate. The medication is delivered in the form of an oral tablet for ease of systemic administration, a feature distinguishing it from non-oral or localized treatments.

The choice to use Sildenafil Citrate facilitates the effective delivery of the active compound following the oral route of administration. The tablet consists of the active ingredient integrated into a stable, solid pharmaceutical excipient matrix, ensuring a precise and standardized dose for adult patients requiring systemic vascular support.

X-FORCE's General Purpose and Action

The general purpose of X-FORCE is to utilize its selective enzyme inhibition to promote vasodilation, facilitating enhanced blood flow. Selective PDE5 inhibitors primarily induce vasodilation. This confirms the drug's fundamental job is to help widen blood vessels to improve circulation.

The ability of this medication to temporarily block the PDE5 enzyme leads directly to the enhanced effects of nitric oxide (NO), promoting the necessary relaxation of smooth muscles in blood vessel walls. This targeted vasodilation provides the foundational physiological action for the drug’s general utility, supporting a typical use scenario where improved localized blood flow is crucial for function.

Regulatory References

NIH LiverTox: Sildenafil

Therapeutic Uses of X-FORCE

What X-FORCE Treats: Main Uses and Benefits

X-FORCE is relevant for easing symptoms associated with conditions involving episodic or fluctuating manifestations. The therapeutic context of X-FORCE involves the management of symptoms associated with Erectile Dysfunction (ED) and Pulmonary Arterial Hypertension (PAH).

Support for Functional Erection Deficits

This domain addresses the common symptomatic pattern of being unable to achieve or sustain an adequate penile erection, which creates noticeable physiological strain. X-FORCE is used to provide physiological support, helping adult men manage symptoms related to physical discomfort. It provides support that may help patients cope more steadily with symptom fluctuations and functional strain.

Chronic Management of Pulmonary Arterial Hypertension (PAH)

In the context of cardiopulmonary disease, X-FORCE is applied in conditions marked by heightened symptoms, such as shortness of breath and fatigue related to systemic imbalance during activity. It is used across the PAH domain where short-term symptom management is appropriate. The medication contributes to easing the overall symptom load and supports general well-being during symptomatic phases.

Alleviation of Severe Peripheral Ischemic Symptoms

X-FORCE is relevant in clinical settings that involve acute or unstable symptom patterns, such as those caused by severe peripheral vascular strain in the extremities. The medication is commonly used to help with these groups of symptoms. It offers symptomatic relief that helps patients cope more steadily and may assist with maintaining functional stability in the extremities.

Quick Fact: Relief for Vascular Symptoms

Therapeutic Focus	Main Symptom Managed	Clinical Context
Sexual Health	Functional erection deficits	Support for acute episodes
Cardiopulmonary	Exertional dyspnea/fatigue	Chronic supportive care
Peripheral Ischemia	Severe vascular strain/pain	Addressing acute symptomatic episodes

Regulatory References

NIH StatPearls overview on Sildenafil

Eligibility and Restrictions for Use

Official Eligibility Rules for X-FORCE

Regulatory documents define strict population eligibility for X-FORCE (Sildenafil), detailing who is approved for use and who is strictly prohibited. Use is generally established for adult men for the ED indication and adult men and women for the PAH indication. The medicine is not indicated for individuals under 18 years of age for the ED indication, though specific pediatric groups (age 1 and older) are approved for the PAH indication.

Category	Regulatory Status
Absolute Contraindications	Use is prohibited with organic nitrates or nitric oxide donors (due to severe blood pressure risk), known hypersensitivity to sildenafil, or concomitant use of riociguat (a guanylate cyclase stimulator).
Disease-Based Exclusions	Use is contraindicated in patients with a history of NAION (vision loss in one eye), severe hepatic impairment (Child-Pugh C) for ED, recent stroke or myocardial infarction (within six months), or severe hypotension (BP <90/50 mmHg).
Conditional Use	Patients with severe renal impairment (creatinine clearance <30 mL/min) or those aged 65 years and older may require a lower starting dose due to altered drug clearance. Caution is advised in individuals with conditions predisposing to priapism (e.g., sickle cell anemia) or anatomical deformation of the penis.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents establish specific restrictions and required precautions when X-FORCE (sildenafil) is co-administered with other medicinal products or substances. All forms of organic nitrates and the guanylate cyclase stimulator Riociguat are formally contraindicated due to the severe risk of potentiating hypotensive effects.

The primary interaction mechanism is pharmacokinetic, as X-FORCE is cleared mainly through the hepatic enzymes CYP3A4 and CYP2C9. Strong CYP3A4 inhibitors, such as Ritonavir and Ketoconazole, significantly increase X-FORCE plasma concentrations. The regulatory label mandates a maximum single dose of 25 mg within a 48-hour period when co-administered with Ritonavir to manage this increased systemic exposure.

Pharmacodynamic and Clearance Considerations

Interaction Type	Interacting Agents	Outcome Documented by Regulators
Pharmacodynamic	Alpha-blockers (e.g., Doxazosin)	Additive blood pressure-lowering effect (hypotension).
Pharmacokinetic	CYP3A4 Inducers (e.g., Bosentan)	Decreased X-FORCE systemic exposure.

In specific populations, severe renal impairment and hepatic impairment are documented to reduce drug clearance, resulting in significantly increased systemic exposure of X-FORCE.

Mechanism of Action

The mechanism of X-FORCE (Sildenafil) is confined to the peripheral vascular system, where it adjusts a naturally occurring process that regulates blood vessel diameter and local circulation.

Targeting the PDE5 Enzyme and cGMP Signal

The core mechanism involves the selective inhibition of the enzyme Phosphodiesterase type 5 (PDE5). This action directly targets the vascular system's regulatory mechanism by preventing the breakdown of the critical second messenger molecule, cyclic Guanosine Monophosphate (cGMP). This preservation of cGMP is essential because it is the molecule that signals the smooth muscle cells to enter a state of relaxation.

Augmenting Vasodilation and Local Blood Flow

X-FORCE functions as a pathway augmenter, meaning its mechanism relies on the prior physiological release of Nitric Oxide (NO). By contributing to sustaining cGMP levels, the drug modulates the natural NO-cGMP signaling cascade, which triggers smooth muscle relaxation in the vessel walls. The resultant vasodilation facilitates localized adjustment of vascular resistance and flow. The overall mechanism constitutes an augmentation of a natural physiological response.

Dosage and Administration Information

How to Use X-FORCE: Administration Guidelines

Administration of X-FORCE (Sildenafil) follows two distinct protocols depending on the condition being addressed: episodic use or chronic management. This differentiation dictates the route, dose, and frequency.

Administration Scope by Indication

Feature	Episodic Use (e.g., Erectile Dysfunction)	Chronic Use (e.g., Pulmonary Arterial Hypertension)
Route of Administration	Oral tablet.	Oral tablet or oral suspension. An Intravenous (IV) bolus injection is a temporary alternative.
Standard Dosing	Starting Dose: 50 mg. Maximum Single Dose: 100 mg.	Standard Dose: 20 mg administered three times a day (TID). Maximum Oral Dose: 80 mg TID.
Frequency and Timing	Taken as needed, no more than once per day. Taken approximately 30 minutes to 4 hours prior to activity.	Administered TID, with doses taken approximately 4 to 6 hours apart.

Procedural and Population-Based Rules

Oral Administration Conditions: Oral tablets may be taken with or without food; however, a high-fat meal can delay the rate of absorption. The oral suspension form requires reconstitution with water and must be shaken prior to use.

Dose Adjustment Protocols: A lower starting dose of 25 mg is used for specific adult patient populations. This lower starting dose is recommended for older adults (over 65 years) and those with severe hepatic or renal impairment when using the episodic regimen. Furthermore, when X-FORCE is used alongside certain strong inhibitors (like Ritonavir), the maximum episodic dose is restricted to 25 mg once every 48 hours.

Missed Dose (Chronic Use): If a chronic dose is missed, it should be taken as soon as remembered. However, a double dose must not be taken to compensate for the skipped one.

Recent Clinical Evidence

Research Evidence / Overview of Studies for X-FORCE

Evidence for Use in Functional Erection Deficits

Research involving X-FORCE was conducted to evaluate outcomes related to functional erection deficits and primarily involved numerous placebo-controlled randomized controlled trials (RCTs). These short-term trials were applied in studies examining patient-reported experiences in adult men with functional erection deficits. The research focused on endpoints reflecting daily functioning or activity level, measured using specialized questionnaires like the IIEF-EF score to capture the patient's perspective.

In these trials, researchers reported how symptoms evolved in the observed populations, documenting the changes measured during the study period compared to those receiving placebo. Studies monitored and described how measured changes evolved across different populations, including men with underlying conditions like diabetes mellitus.

Evidence for Use in Pulmonary Arterial Hypertension (PAH)

For conditions marked by functional limitations like Pulmonary Arterial Hypertension (PAH), X-FORCE was evaluated in intermediate-term placebo-controlled RCTs. These studies were conducted during periods of increased symptom activity and focused on assessing measured changes in the physical capacity of patients with symptomatic PAH. The research monitored endpoints that included measures of systemic or functional imbalance and exercise capacity, such as the Six-Minute Walk Distance (6MWD).

Trials documented patterns observed in the studies by reporting the change in 6MWD measurement from baseline compared to the placebo groups. Studies also reported on patterns related to the incidence of clinical worsening events across the groups observed. Long-term effects for this indication are not fully established, requiring extended follow-up studies to characterize.

Research Gaps and Unanswered Questions

The existing research landscape highlights what is known — and what is still uncertain. For both primary uses, long-term effects are not fully established, as follow-up durations were limited in many pivotal trials. This means that long-term data describing observed changes over several years are less readily available.

Comparative evidence is lacking against all other similar products, meaning there is limited research directly comparing X-FORCE's measured outcomes with every alternative option. Furthermore, for less common uses like addressing peripheral symptoms, the evidence is described as limited and heterogeneous, relying on small sample sizes and specialized observational settings. The research does not determine whether an individual will respond similarly, as study results reflect the specific conditions under which they were conducted.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about X-FORCE (FAQ)

Q: What is the maximum amount of X-FORCE I can take in a day for ED?

According to official regulatory guidelines for episodic use (Erectile Dysfunction), the medication is taken no more than once per day. The highest single dose described in official prescribing information is 100 mg.

Q: Is X-FORCE safe for children, and what is the age limit for taking it?

The use of X-FORCE for the ED indication is generally not established for individuals under the age of 18. However, official information indicates that for the treatment of Pulmonary Arterial Hypertension (PAH), the drug is approved for use in specific pediatric patient groups, including children aged 1 year and older.

Q: What specific prescription drugs or supplements should I avoid because they interact badly with X-FORCE?

Official product information emphasizes that X-FORCE is strictly contraindicated (should not be used) with all forms of organic nitrates and guanylate cyclase stimulators, due to the risk of severe hypotension (low blood pressure). Caution is also advised when it is used alongside certain strong CYP3A4 inhibitors (like Ritonavir and Ketoconazole) or alpha-blockers, as these may be associated with an additive blood pressure-lowering effect.

Q: Are there any long-term studies that show the safety or effectiveness of X-FORCE?

Studies and official information indicate that the pivotal clinical trials used for approval were generally short-term. While long-term effects are not fully established across all indications, some extended studies—including open-label extension trials—have evaluated the safety and tolerability of the medication over periods lasting up to four years.

Q: How quickly does X-FORCE start working after I take the oral tablet?

Regulatory information indicates that X-FORCE for episodic use is typically recommended to be taken about one hour before activity. Official guidelines permit the drug to be taken anywhere within a timeframe of 30 minutes to four hours prior to activity.

Q: What do the different tablet colors or markings mean on the X-FORCE pill?

Official drug labels and prescribing information describe the physical appearance of the tablets. This includes details like the color (e.g., blue), shape (e.g., rounded-diamond), and specific debossed markings, which are used to identify the drug’s manufacturer and the dosage strength.

Q: Can women take X-FORCE for any of its approved uses, or is it just for men?

According to official indications, X-FORCE (Sildenafil) for the purpose of treating Erectile Dysfunction (ED) is established for adult men. However, for the treatment of Pulmonary Arterial Hypertension (PAH), the drug is approved for use in both adult men and women.

Q: Where can I find official, unbiased drug information or the full FDA label for X-FORCE?

The full, official prescribing information (the FDA label) is available to the public. You can find this authoritative drug information on government-run websites such as the FDA’s Drugs@FDA database or the National Library of Medicine’s DailyMed website.

How should X-FORCE be stored and disposed of?

How to Store and Dispose of X-FORCE

The storage and disposal of X-FORCE (Sildenafil Citrate) tablets must strictly follow the conditions specified in official regulatory labeling.

Storage Requirements

X-FORCE must be stored at Controlled Room Temperature (CRT), defined as 20 C to 25 C (68 F to 77 F). The medicine must be kept in its original container and the container kept tightly closed to protect the tablets from moisture.

Storage Restriction	Requirement
Temperature	Controlled Room Temperature (20 C to 25 C)
Protection	Keep tightly closed; protect from moisture
Safety	Keep out of the sight and reach of children

Disposal Instructions

Unused or expired X-FORCE must not be disposed of in household waste or flushed down the toilet. Disposal must be conducted according to local regulatory requirements for pharmaceutical waste, typically by returning the medicine to a pharmacy or a designated collection program.

Action	Official Regulatory Instruction
Immediate Help	Contact emergency services (e.g., 911) or a Poison Control Center immediately.
When to Seek Care	Seek urgent medical attention upon the first signs of suspected overdose, including any significant change in consciousness or difficulty breathing.
Management	Supportive measures to maintain a patent airway and assisted ventilation are primary. The official label specifies the use of a pharmacological antidote, administered under medical supervision.

X-FORCE